How is NMRA intrinsic value estimated?
We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for NMRA.
Intrinsic value of Neumora Therapeutics, Inc. Common Stock (NMRA)
Live valuation data for Neumora Therapeutics, Inc. Common Stock (NMRA) is not available right now. Please try again shortly.
Intrinsic Value (Fair Value): Unlock fair value
Downside: Data not available
Margin of Safety: Unlock fair value
Current Price: $42.00
Valuation: Data not available
Confidence: Data not available
Visual Bar
Market Price $42.00Intrinsic Value Locked
Undervalued ✅Fair Value ⚖️Overvalued ❌
This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.
Intrinsic Value checker
Search our company database (same as the site header), pick a match, or type a ticker to open its intrinsic value analysis.
Is Neumora Therapeutics, Inc. Common Stock (NMRA) undervalued or overvalued?
Valuation verdict for Neumora Therapeutics, Inc. Common Stock will appear when live upside data is available.
Fair value vs market price — Neumora Therapeutics, Inc. Common Stock (NMRA)
Unlock premium access to view the live fair value comparison against current market price for NMRA.
Frequently Asked Questions - NMRA
Is NMRA undervalued or overvalued right now?
NMRA is currently shown as overvalued based on the difference between market price and intrinsic value.
How should I use the confidence score?
The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.
Related companies — intrinsic value
Peers for NMRA: open their intrinsic value pages.